Anticholinesterase agent; having a cholinesterase effect through a reversible acetylcholinesterase inhibition and enhancing the action of acetylcholine. Improves neuromuscular transmission, increases the motility of the gastrointestinal tract, increases the tone of urinary bladder, bronchi, the secretion of exocrine glands. Prescribed for myasthenia gravis, postoperative intestinal atony, atonic constipation, bladder atony, post-traumatic movement disorders; flaccid paralysis; residual explication of polio, encephalitis, violation of emptying the bladder after gynecological surgery and childbirth.
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Mestinon Product Description
Mestinon is a parasympathomimetic agent, used for controlling the slurred speech, muscle weakness and other symptoms of myasthenia gravis. The drug can also be prescribed, if a surgery has caused a temporary urinary retention.
Mestinon is prescribed to patients of all ages, suffering from myasthenia gravis. Children under 6 years of age should begin treatment of this autoimmune disorder with Mestinon dosage of 30mg (half a pill). The recommended Mestinon dosing regimen may be changed several times a week. Clinically meaningful results are achieved with a dose of 30 to 120mg Mestinon several times a day.
If you forget to take your usual Mestinon dose, you may take it as soon as possible, except if it is almost time for the next dose of this antimyasthenic agent. In this case, just skip the missed Mestinon dose and return to your prescribed treatment regimen.
The average duration of Mestinon action is 3.5 hours. The effect can be prolonged up to 6 hours, if you take the tablets before going to bed.
Keep Mestinon in original packaging in a dark, dry place at temperature not exceeding 25ºC.
Mestinon Safety Information
Large doses of the antimyasthenic agent Mestinon should be avoided in patients with pulmonary, cardiovascular, psychiatric, or gastrointestinal abnormalities. People taking Mestinon aged 50 and more are more susceptible to supraventricular dysrhythmias, than younger patients.
The material about myasthenia gravis, provided in the review about Mestinon, is for information purposes only and in no way should be considered a replacement for expert medical consultation of a primary health care worker. The online pharmacy assumes no responsibility for the damage, detriment or harm, resulted from the use of information on antimyasthenic agent Mestinon.
Mestinon Side Effects
Typically, Mestinon causes adverse reactions with low intensity and frequency. The most common adverse reactions of Mestinon are fasciculation, miosis, hypersalivation, muscle spasms or weakness, allergic reactions (including rash and urticaria), diaphoresis, increase of peristalsis and bronchial secretions. Gastrointestinal adverse reactions of Mestinon are diarrhea, vomiting, nausea and abdominal cramps. Other, less often adverse reactions of Mestinon are: emesis, hypotension, lacrimation, bloating, urinary incontinence, bradycardia, and flatulence.